OVERVIEW

National Lipid Association (NLA) Masters in Lipidology Course is organized by National Lipid Association (NLA).

Launch Date: September 15, 2021
Expiration Date: September 15, 2024

Program Overview:
This intensive training course offers an in-depth review of the core curriculum in Clinical Lipidology for healthcare professionals who desire to practice at an advanced level within the field. The new case-based, interactive agenda will improve your clinical decision making skills and help prepare you for certification by the American Board of Clinical Lipidology (ABCL) or the Accreditation Council in Clinical Lipidology (ACCL). For those not preparing for certification, the course provides an excellent update and refresher on core concepts in Lipidology. Learn from leading experts, assess your knowledge of lipid science and advance your personal standard of practice.

Learning Objectives:
At the conclusion of this activity, participants should be able to:
• Describe genetic disorders affecting lipoprotein metabolism.
• Diagnose genetic disorders using lipid profiles.
• Review the role of biomarkers & subclinical atherosclerosis testing (imaging) in assessment & prevention of ASCVD.
• Assess differences in clinical practice recommendations & guidelines.
• Describe evaluation criteria for the classification of patients with metabolic syndrome and/or obesity.
• Compare and contrast the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of dyslipidemia.
• Identify the frequency and secondary causes of statin intolerance and treatment options for statin intolerant patients.
• Assess the side effects of lipid-altering drugs.
• Describe novel therapies in development.
• Assess the impact of diet, exercise and behavior modifications on cardiovascular risk and risk factors.
• Interpret evidence from recent literature on dietary cholesterol.
• Compose a treatment plan for patients incorporating dietary changes.
• Judge evidence in published literature for its application to clinical practice.
• Evaluate data from key clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention.
• Discuss the evidence base for the use of statin and non-statins in the primary & secondary prevention of ASCVD.
• Evaluate the evidence base for the use of non-statin therapy in combination with moderate to high intensity statin therapy.
• Review the treatment goals & targets of different lipid guidelines.
• Appraise treatment approaches for dyslipidemia in specific populations based on age, gender, ethnicity, and cultural variables.
• Compose a treatment plan for patients with complex lipid disorders.
• Distinguish roles in a team-based approach to care.
• Examine historic investigations into clinical lipidology and describe their current clinical application.
• Review lipid-altering drugs in development.
• Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

ACCREDITATION & CREDITS

Credit Designation
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.00 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
The National Lipid Association designates this Enduring Internet activity for a maximum of 15.00 AMA PRA Category 1 Credits^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit^TM from organizations accredited by ACCME.
Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 15.0 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.
Pharmacists
Universal Activity Number – JA0007192-0000-21-033-H01-P (Application)
This Activity has been approved for 15.0 contact hour(s) (1.5 CEUs) of the Accreditation Council for Pharmacy Education.
Nursing
The maximum number of hours awarded for this CE activity is 15.0 contact hours.
For the advanced practice nurse, this activity has 2.2 contact hours of pharmacotherapy content.

15 AMA PRA Category 1 Credits™

15 Contact Hours

TARGET AUDIENCE

PhysicianNursingPharmacistPhysician AssistantAdvanced Practice NurseCardiologistsHealthcare professionalNursesHealthcare ManagementLipidologyNurse PractitionersDietitian